📰 Weekend read Navigating the evolving pharmaceutical landscape, understanding the integration of cutting-edge technology into drug development and manufacturing is crucial. "Drug services firms begin embracing AI" (https://lnkd.in/dSXGGBxa) article from C&EN offers valuable insights into how leading CDMOs are leveraging AI and automation to enhance efficiency, accelerate timelines, and ensure superior quality in drug synthesis and quality control.🔬✨ As highlighted by our colleague Jan Vertommen, PhD, these advancements directly impact the speed and reliability of bringing critical therapies to market. A valuable read to understand the future of our drug development.
Love this
--
3dThanks for sharing